
New Alzheimer’s Drug Shows Promise in Slowing Cognitive Decline
New Alzheimer’s Drug Shows Promise A new drug called Donanemab is offering hope for those with Alzheimer’s disease. Recent clinical trials suggest it can slow down cognitive decline. This is particularly true for people in the early stages of the disease. Clinical Trial Results The trials involved many participants. Researchers carefully tracked their cognitive abilities…